English(EN) XtalPi, the Hong Kong-listed AI drug discovery firm founded by MIT-trained physicists, has posted its first full-year profit of RMB 258 million (USD 36 million)

AI药物发现公司XtalPi实现首个全年盈利3600万美元

作者 PulseAugur 编辑部 · [1 个来源] · 2026-04-30 12:33

XtalPi是一家总部位于香港的AI药物发现公司，已宣布其首个全年盈利，报告称净利润为人民币2.58亿元（合3600万美元）。这一财务里程碑是在8亿元人民币（合1.12亿美元）的收入基础上实现的，这主要归功于与一家美国制药公司达成的重大合同。该公司还披露了其庞大的现金储备，持有超过70亿元人民币（合9.8亿美元）。 AI

影响展示了AI在药物发现等专业领域的日益增长的可行性，可能预示着AI驱动的生物技术盈利新趋势。

排序理由 AI公司报告首个全年盈利和大量现金储备。

在 Mastodon — fosstodon.org 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

报道来源 [1]

Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] · 2026-04-30 12:33

XtalPi, the Hong Kong-listed AI drug discovery firm founded by MIT-trained physicists, has posted its first full-year profit of RMB 258 million (USD 36 million)

XtalPi, the Hong Kong-listed AI drug discovery firm founded by MIT-trained physicists, has posted its first full-year profit of RMB 258 million (USD 36 million) on revenue of RMB 800 million (USD 112 million), driven by a major US pharma contract. The company holds over RMB 7 bil…

报道来源 [1]

XtalPi, the Hong Kong-listed AI drug discovery firm founded by MIT-trained physicists, has posted its first full-year profit of RMB 258 million (USD 36 million)

相关实体

相关话题